Skip to main content
Clinical Trials/EUCTR2014-001619-37-NL
EUCTR2014-001619-37-NL
Active, not recruiting
Phase 1

Contrast enhanced Diffusion-weighted Magnetic Resonance Imaging for detection of pathologic lymph nodes in ovarian cancer – a feasibility study. - MILO

Maastricht University Medical Centre0 sites20 target enrollmentJune 3, 2014

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Ovarian Cancer - diagnosis of lymph nodes
Sponsor
Maastricht University Medical Centre
Enrollment
20
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 3, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
Maastricht University Medical Centre

Eligibility Criteria

Inclusion Criteria

  • Non\-pregnant female
  • Expected FIGO stage IIB\-IV epithelial ovarian carcinoma
  • Scheduled for primary debulking surgery
  • Written informed consent
  • At least 18 years of age.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 10
  • F.1\.3 Elderly (\>\=65 years) yes

Exclusion Criteria

  • Patients estimated to have more benefit from neoadjuvant chemotherapy
  • Ineligibility to undergo MRI
  • Ineligibility to receive contrast agent
  • Previous para\-aortic or pelvic lymphadenectomy
  • History of a malignant tumour.
  • Pregnant or lactating patients.

Outcomes

Primary Outcomes

Not specified

Similar Trials